Reg 74(5) certificate filed, no demat/remat activity in Q2 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹111.00

prior close

₹108.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+1.6% vs market

Pharmaceuticals peers, median of 172sector-0.6%+0.6% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-1.6+1.6-0.6+0.6

Next day

+1.8-1.0+2.7-0.7+2.4

-1.8-2.6+0.8-1.9+0.1

+0.9-5.1+6.0-3.5+4.4

+0.9-6.1+7.0-4.4+5.3

-1.8-8.3+6.5-6.1+4.3

-0.9pendingpending-2.9+2.0

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company's Registrar Venture Capital and Corporate Investments has filed a Regulation 74(5) certificate with BSE confirming that no securities were received for dematerialization or rematerialization during the quarter ended 30 September 2026. This is a routine quarterly compliance submission required under SEBI DP Regulations, 2018.

Likely market impact

Routine regulatory filing, no material impact on shareholders or stock price.